On Friday, the European Commission approved the updated corona vaccine from the Mainz-based manufacturer Biontech and its US partner Pfizer. It is to be used in the vaccination campaigns of the EU countries this autumn against the dominant variant Omicron XBB.1.5. The Comirnaty vaccine is the third adapted vaccine to be used in the EU. The commission approved the use for adults, children and infants from six months. The European Medicines Agency (EMA) approved the vaccine earlier this week. She recommends vaccination with the updated vaccine regardless of previous corona vaccinations. Biontech and Pfizer had announced that they would be able to deliver the vaccine to the EU countries immediately after approval.
EU approves corona vaccine – economy
